PRAX Q2 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$781,000

Gross Profit

-$25M-3179.6% margin

Operating Income

-$35M-4476.3% margin

Net Income

-$34M-4393.3% margin

EPS (Diluted)

$-7.38

QoQ Revenue Growth

+14.3%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$133M

Total Liabilities

$28M

Stockholders' Equity

$106M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$781,000	$0	—
Gross Profit	-$25M	-$3M	-731.4%
Operating Income	-$35M	-$60M	+42.1%
Net Income	-$34M	-$60M	+43.0%

Revenue Segments

License

$800,000100%